• Product NameDiroximel Fumarete
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityDiroximel fumarate, also known as ALKS-8700, is a prodrug of monomethyl fumarate in a controlled-release formulation that rapidly and efficiently converts to MMF in the body.
• Target NameOthers
• CAS No. 1577222-14-0
• Calculated MW 255.22
• Formulation C11H13NO6
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Others
  SMILES:COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O
  Pathways:Others
  Receptor:Others
  Boling pt:
  Melting pt:
  Solubility:Soluble in DMSO
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Alkermes Announces Positive Clinical Trial Results and Streamlined Registration Pathway for ALKS 8700 for Treatment of Multiple Sclerosis. October 29, 2015 07:00 AM Eastern Daylight Time.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting